Acute and Emergency Dermatology Flashcards
(50 cards)
Examples of acute and emergency dermatology
-Acute (and chronic) urticaria (including papular urticaria / insect bites / stings)
-Drug reactions including Stevens-Johnson syndrome / toxic epidermal necrolysis spectrum and the differential
diagnosis of viral exanthem
-Extensive blistering eruptions involving the skin +/- mucous membranes
-Erythroderma
-Eczema with secondary infection (including eczema herpeticum)
-Generalised pustular psoriasis
-Necrotising fasciitis
-Staphylococcal scalded skin syndrome
What are blisters?
-Reflect the accumulation of extracellular fluid either within the epidermis; between the epidermis and the basement membrane; or between the dermis and the basement membrane.(Extracellular fluid deeper within the dermis is a weal, as you see in urticaria)
What causes the fluid accumulation in blisters?
-Loss of adhesion between keratinocytes, or between the keratinocytes and the basement membrane, or the attachments of the dermis to the basement membrane.
-The defect in adherence may be due to defects in adhesion molecules on the cell membrane, or because the cell itself has lost it structural integrity and cannot metabolically support the molecules at the cell membrane
Describe epidermolysis bullosa
-These disorders often present at birth or soon after birth, and are mostly due to inherited defects in molecules that are involved in adhesion between different components of skin (keratins and desmosomes)
-Can produce severe scarring
Mechanism for inactivating adhesion molecules
- Mutation
- Autoantibodies (pemphigus)
- Bacterial toxins
What are the two types of pemphigus?
-Pemphigus vulgaris and pemphigus foliaceous
=Pempphigussss= superficial
=In pemphigus foliaceous, IgG antibodies act against desmoglein 1 (Dsg1)
=In pemphigus vulgaris the attack is on desmoglein 3 (Dsg3) +/- desmoglein 1 (Dsg1)
Features of desmoglein proteins
- Different desmogleins co-expressed in the same cells can compensate for the loss of the other.
- The pattern of expression of Dsg1 and Dsg3 is different within skin.
- The pattern of expression of Dsg1 and Dsg3 differs between skin and mucosae.
Describe compensation between Dsg1 and Dsg3
-Dsg1 is present throughout skin, but is expressed most highly in the superficial layers.
-Dsg3 is expressed in skin in the basal and immediate suprabasal layers, but not in the superficial layers.
-If there are antibodies to Dsg1, as you see in pemphigus foliaceous, inactivation of Dsg1 leads to superficial blisters. This is because Dsg1 is the only one of the two desmogleins expressed in the superficial layers of skin, and so Dsg3 cannot compensate.
-If you have antibodies to Dsg3 only, then Dsg1 in skin can compensate for the lack of Dsg3: there is little or no blistering of skin.
-If however you have antibodies to Dsg1 and Dsg3 then blisters of skin result, and the result is pemphigus vulgaris: there is nothing left to do the ‘compensating’
Dsg1 and Dsg3 compensation in the mucosae
-In the mucosae, there is very little Dsg1 expression and Dsg3 is expressed in all layers.
-Antibodies or inactivation of Dsg1 therefore produces no mucosal phenotype (pemphigus foliaceous).
-However, antibodies to Dsg3 will cause mucosal blisters and few or no skin blisters (mucosal dominant pemphigus vulgaris).
-However, if you have antibodies to both Dsg1 andDsg3 then you will have mucosal and extensive skin disease (mucocutaneous pemphigus vulgaris)
Epidemiology of pemphigus
-Can occur at any age but it is most common in middle age.
-It is more common in some genetic ancestral groups such as certain Jewish populations
What is Fogo selvagem?
-Rare variant of pemphigus foliaceous
-Arthropods may be important as a vector for an infective agent that precipitates the disease.
-‘Flaming fire’= burning pain.
Clinical features of pemphigus
-Superficial blisters that break easily
-Patients may just present with erosions and crusts and be misdiagnosed as having eczema
(foliaceous more superficial than in vulgaris)
-Mucosal involvement in pemphigus vulgaris may involve the eyes, mouth, pharynx, larynx, oesophagus as well as the genitalia.
-Virtually all patient with pemphigus vulgaris develop painful erosions of the mouth.
-The Nikolsky sign is usually positive: if you rub apparently normal skin, a blister develops; or if you press on a blister, it spreads outwards.
-In pemphigus foliaceous the rash is common on the scalp, the face, chest and upper back. It is easily misdiagnosed as seborrhoeic dermatitis (because there is scaling, crusting, and erythema but no obvious blisters)
Diagnosis of pemphigus
-Biopsy of the blister will show acantholysis (separation of keratinocytes from each other)
-A peri-lesional biopsy for direct immunofluorescence (IF) will confirm IgG intercellular staining within the epidermis (the exact location depends on whether it is pemphigus foliaceous or vulgaris).
-Indirect immunofluorescence against circulating antibodies are usually present and correlate to some extent with disease activity
Management of pemphigus
-Large doses of systemic corticosteroids are required and immunosuppressive sparing agents such as azathioprine or mycophenolate are frequently used
-Drug treatment may be tapered off as circulating antibodies decline
-Patients who do not respond to the above may be treated with intravenous immunoglobulin, anti CD-20 antibodies (anti B cells) or cyclophosphamide
-Can be paraneoplastic syndrome
What is pemphigoid?
-Antibody-mediated disease, only in this case the target antigen (or antigens) are against molecules involved in the anchoring of keratinocytes to the basement membrane (hemidesmosomes).
-As with pemphigus, the antibodies are not an epiphenomenon — they cause the disease. Pemphigoid is much more common than pemphigus
Clinical features of pemphigoid
-Can occur at any age but is usually seen in those over 60.
-Its incidence may be increasing for reasons that are not understood.
-It is the most common immunobullous disorder.
-A typical clinical scenario, would be the development of itchy urticated lesions, which may precede the onset of blisters by several months.
=The early rash may be diagnosed as eczema and on occasions patients present with itch for several years before the development of any cutaneous signs.
-The blisters are larger, and more tense and robust than those found in pemphigus.
-Involvement of the mucosa is only found in ~20% patients (contrast with pemphigus vulgaris (~100%); and pemphigus foliaceous ~(0%)).
What is pemphigoid gestationis?
-Type of pemphigoid seen during pregnancy (it was previously called Herpes Gestationis, but has nothing to do with the herpes virus).
-It is best viewed as the result of aberrant expression of paternal MHC on the placenta, and a maternal antibody response to placenta basement proteins, that cross react with the target hemidesmosomal proteins in skin
Diagnosis of pemphigoid
Biopsies show an eosinophil rich inflammatory infiltrate and sub epidermal blisters with IgG immunofluorescence staining along the basement membrane visible on peri-lesional skin
Treatment of pemphigoid
-Systemic corticosteroids/ localised pemphigoid, or even people with more diffuse pemphigoid, have been treated with very potent topical corticosteroids.
=If the rash is more widespread, then the topical corticosteroids have to be applied to all of the skin’s surface (ie all the non-blistered areas, too) — this is often impractical.
-Treatment is still usually with systemic prednisolone, with or without azathioprine, as a steroid sparing agent.
-Occasionally other immunosuppressives will need to be used.
-The course of the disease is chronic and the aim is to use the smallest dose of systemic immunosuppression compatible with clinical resolution.
=Remission will eventually occur in most patients.
-Mortality of patients with pemphigoid still remains significantly above that of matched controls (~ 20-40% at one year in some series), some of which likely reflects infections secondary to the immunosuppression.
-Other treatments for those that do not respond to standard management include intravenous immunoglobulins (IVIG), anti CD20 antibodies or cyclophosphamide
What is dermatitis herpetiformis?
-Skin immunobullous disorder that is associated with GI gluten sensitivity.
-Most patients have evidence of this associated gluten sensitive enteropathy, but only a minority have clinical GI symptoms.
Pathophysiology of DH
-Gliaden is a component of gluten.
=Once gliaden is absorbed, it is a substrate for a transglutaminase enzyme in the GI tract.
=Some people with particular HLA groups see this complex as foreign, and helper T cells lead to the production of IgA antibodies that interact with this gliaden/transglutaminase complex.
=A cross reaction with another type of transglutaminase that is found in skin then occurs.
=Epidermal transglutaminase, which plays a key role in the production of the cornified envelope, diffuses into the dermis, and circulating IgA antibodies bind to the transglutaminase there, resulting in immune complex deposition.
=This leads to the recruitment of neutrophils and the release of proteases.
=The result is a neutrophil abscess, with positive immunofluorescence staining for IgA within the dermal papillae.
Clinical features of DH
-Patients with dermatitis herpetiformis have very intense itch, an itch that is often described as burning
-Small clusters of vesicles are present, most commonly on the wrists, extensor aspects of the elbow and knees, and the sacrum and buttocks.
-The rash may be much more extensive
-There is no mucosal involvement
-The intense itch (and hence scratch) mean that intact vesicles may not be easily found.
-term herpetiformis comes from the fact that there are often clusters of small blisters resembling the blisters seen in herpes simplex infection, but infection does not play a role
Diagnosis of DH
-DH is a lifelong disease and immunopathologic confirmation of the diagnosis is essential (biopsy with immunofluorescence).
=Small polymorph abscesses in the upper dermis are visible, and direct immunofluorescence shows granular deposition of IgA in the papillary tips of the dermis.
-80% of patients with DH will have anti-endomysial antibodies (“GI transglutaminase”)
Management of DH
-Gluten free diet, which reduces their requirements for medication and diminishes their increased risk of small bowel lymphoma.
-Dapsone: itching stopped within 48-72 hours the diagnosis was taken as confirmed.
=Note the occasional rare side effect of dapsone: agranulocytosis. More predictable is haemolytic anaemia. Patients need close monitoring for several months after starting the drug